Subtitle
Finding Value for Protons: The Case of Prostate Cancer?
Subtitle
Finding Value for Protons: The Case of Prostate Cancer?
Proto therapy Time
April 2018
Executive summary
A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile dysfunction. Regarding rectal toxicity, some studies found PBT was worse, others suggested PBT was better, and still others concluded there was no meaningful difference at all.
A comparative trial has commenced the Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL) trial.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
April 2024
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
Proton Therapy Publication
November 2023
Proton Therapy Mediates Dose Reductions to Brain Structures Associated with Cognition in Children with Medulloblastoma.
Proton Therapy Publication
October 2023
Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy.
Proton Therapy Publication
September 2023
Ultra-High Dose-Rate Proton FLASH Improves Tumor Control.
Proton Therapy Publication
June 2023
The current status of FLASH particle therapy: a systematic review.
Proton Therapy Publication
May and June 2023
ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.
Proton Therapy Publication
April 2023
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
Proton Therapy Publication
March 2023
A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Proton Therapy Publication
November 2022
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.